acetylshikonin has been researched along with Disease Models, Animal in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (75.00) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Dong, Z; Gu, T; Jin, G; Liu, K; Lu, N; Mangaladoss, F; Qiao, Y; Tian, X; Zhao, R; Zhao, S | 1 |
| Hong, M; Li, J; Li, S; M Almutairi, M | 1 |
| He, Y; Li, Q; Su, M; Zeng, J; Zhu, B | 1 |
| Hong, Z; Li, Z; Peng, Z; Shao, R; Zhao, Y | 1 |
| Su, M; Zeng, J; Zhu, B | 1 |
| Cheng, L; Fan, XH; Yan, AH | 1 |
| He, Y; Li, QS; Su, ML; Zhu, BH | 1 |
| Chang, LC; Kuo, SC; Raung, SL; Wang, JP | 1 |
8 other study(ies) available for acetylshikonin and Disease Models, Animal
| Article | Year |
|---|---|
Acetylshikonin inhibits inflammatory responses and Papain-like protease activity in murine model of COVID-19.
Topics: Animals; Anthraquinones; COVID-19; Disease Models, Animal; Mice; Papain | 2022 |
Acetylshikonin Sensitizes Hepatocellular Carcinoma Cells to Apoptosis through ROS-Mediated Caspase Activation.
Topics: Animals; Anthraquinones; Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; Biomarkers, Tumor; Carcinoma, Hepatocellular; Caspases; Cell Line, Tumor; Disease Models, Animal; DNA Damage; Drug Synergism; Drugs, Chinese Herbal; Hep G2 Cells; Humans; Immunohistochemistry; Liver Neoplasms; Mice; Models, Biological; Reactive Oxygen Species; Signal Transduction; TNF-Related Apoptosis-Inducing Ligand | 2019 |
Acetylshikonin from Zicao attenuates cognitive impairment and hippocampus senescence in d-galactose-induced aging mouse model via upregulating the expression of SIRT1.
Topics: Aging; Alzheimer Disease; Animals; Anthraquinones; Cellular Senescence; Cognitive Dysfunction; Disease Models, Animal; Galactose; Hippocampus; Inflammation; Male; Maze Learning; Mice; Nootropic Agents; Oxidative Stress; Random Allocation; Sirtuin 1; Spatial Memory; Up-Regulation | 2018 |
Acetylshikonin from Zicao ameliorates renal dysfunction and fibrosis in diabetic mice by inhibiting TGF-β1/Smad pathway.
Topics: Animals; Anthraquinones; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Models, Animal; Drugs, Chinese Herbal; Epithelial-Mesenchymal Transition; Fibrosis; Gene Expression; Kidney; Male; Mice, Inbred C57BL; Phosphorylation; Phytotherapy; Signal Transduction; Smad Proteins; Streptozocin; Transforming Growth Factor beta1 | 2018 |
Autophagy is involved in acetylshikonin ameliorating non-alcoholic steatohepatitis through AMPK/mTOR pathway.
Topics: AMP-Activated Protein Kinases; Animals; Anthraquinones; Autophagy; Disease Models, Animal; Male; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; TOR Serine-Threonine Kinases | 2018 |
Ameliorative effect of acetylshikonin on ovalbumin (OVA)-induced allergic rhinitis in mice through the inhibition of Th2 cytokine production and mast cell histamine release.
Topics: Administration, Oral; Allergens; Animals; Anthraquinones; Cytokines; Disease Models, Animal; Histamine Release; Immunologic Factors; Injections, Intraperitoneal; Mast Cells; Mice; Ovalbumin; Rhinitis, Allergic; Th2 Cells; Treatment Outcome | 2019 |
Efficacy of Acetylshikonin in Preventing Obesity and Hepatic Steatosis in db/db Mice.
Topics: Animals; Anthraquinones; Anti-Inflammatory Agents; Aspartate Aminotransferases; Body Weight; Cytokines; Disease Models, Animal; Eating; Fatty Acids, Nonesterified; Lipid Metabolism; Mice; Non-alcoholic Fatty Liver Disease; Obesity; Triglycerides | 2016 |
Inhibition of hind-paw edema and cutaneous vascular plasma extravasation in mice by acetylshikonin.
Topics: Adrenalectomy; Animals; Anthraquinones; Bradykinin; Capillary Permeability; Cell Degranulation; Dexamethasone; Diphenhydramine; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Drugs, Chinese Herbal; Edema; Glucuronidase; Glycogen; Hindlimb; Histamine; Indomethacin; Liver; Mast Cells; Methysergide; Mice; p-Methoxy-N-methylphenethylamine; Polymyxin B; Substance P | 1995 |